Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Negro

Showing results (201-210 of 231) with videos related to

Pageof 24
Sort By:
Gut|February 13, 2004
Steatosis affects chronic hepatitis C progression in a genotype specific wayL Rubbia-Brandt, P Fabris, S Paganin, et al.
Liver|August 1, 1993
Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver diseaseP Manzini, P L Calvo, M R Brunetto, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infectionA de Gottardi, V Pazienza, P Pugnale, et al.
Journal of Viral Hepatitis|January 15, 2010
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis CC Sgier, B Müllhaupt, T Gerlach, et al.
Journal of Medical Virology|November 24, 1999
Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosisF Negro, K Samii, L Rubbia-Brandt, et al.
Swiss Medical Weekly|February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in SwitzerlandK Overbeck, J F Dufour, B Müllhaupt, et al.
Clinical and Diagnostic Virology|May 1, 1997
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot studyD Flichman, P Colombatto, A Randone, et al.
Journal of Viral Hepatitis|December 13, 2012
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4N Antaki, S Bibert, K Kebbewar, et al.
Journal of Viral Hepatitis|January 1, 1995
The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferonF Negro, M L Abate, A Mondardini, et al.
Fertility and Sterility|August 1, 1985
Renin-like activity in ovarian follicular fluidL A Fernandez, B C Tarlatzis, P J Rzasa, et al.
Pageof 24

Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Gut|February 13, 2004
Steatosis affects chronic hepatitis C progression in a genotype specific wayL Rubbia-Brandt, P Fabris, S Paganin, et al.
Liver|August 1, 1993
Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver diseaseP Manzini, P L Calvo, M R Brunetto, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infectionA de Gottardi, V Pazienza, P Pugnale, et al.
Journal of Viral Hepatitis|January 15, 2010
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis CC Sgier, B Müllhaupt, T Gerlach, et al.
Journal of Medical Virology|November 24, 1999
Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosisF Negro, K Samii, L Rubbia-Brandt, et al.
Swiss Medical Weekly|February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in SwitzerlandK Overbeck, J F Dufour, B Müllhaupt, et al.
Clinical and Diagnostic Virology|May 1, 1997
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot studyD Flichman, P Colombatto, A Randone, et al.
Journal of Viral Hepatitis|December 13, 2012
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4N Antaki, S Bibert, K Kebbewar, et al.
Journal of Viral Hepatitis|January 1, 1995
The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferonF Negro, M L Abate, A Mondardini, et al.
Fertility and Sterility|August 1, 1985
Renin-like activity in ovarian follicular fluidL A Fernandez, B C Tarlatzis, P J Rzasa, et al.
Pageof 24